Metabolomics in Drug Discovery

Metabolomics is being used in Drug Discovery and in development from lead compound discovery to post approval drug surveillance. Metabolomics can help in finding potential new sites for therapeutic intervention by identifying metabolic changes. Metabolomics can provide activity information about possible novel drugs and drug scaffolds, indicate interesting targets for drug development and suggest binding partners of compounds. Furthermore, metabolomics can be used for the discovery of novel natural products and in drug development. Metabolomics can enhance the discovery and testing of new drugs and provide insight into the on- and off-target effects of drugs.

  • Drug metabolism during drug design and development
  • Metabolites in identification of drug targets
  • Metabonomics in preclinical pharmaceutical discovery and development
  • Toxicology and drug metabolism
  • QSAR and ligand-receptor models
  • Applications in Drug Development

Related Conference of Metabolomics in Drug Discovery

May 10-11, 2019

13th International Conference on Proteomics, Genomics and Bioinformatics

| Radisson Hotel Narita | Tokyo, Japan
May 10-11, 2019

8th Asia Pacific Glycobiology Congress

Tokyo, Japan
May 17-18, 2019

2nd International Conference on Computational Biology and Bioinformatics

| Holiday Inn Singapore Atrium | Singapore
July 11-12, 2019

8th Glycobiology World Congress

Zurich, Switzerland
May 10-11, 2019

4th International Conference on Enzymology & Molecular Biology

| Radisson Hotel Narita | Tokyo, Japan
October 07-08, 2019

4th International Conference on Molecular Biology & Nucleic Acids

Chicago, Illinois, USA

Metabolomics in Drug Discovery Conference Speakers

Recommended Sessions

Related Journals

Are you interested in